MiR-210: More than a silent player in hypoxia

IUBMB Life

Volumn 63, Issue 2, 2011, Pages 94-100

  Devlin, Cecilia ^a   Greco, Simona ^b   Martelli, Fabio ^c   Ivan, Mircea ^a  

^a INDIANA UNIVERSITY   (United States)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

apoptosis; cancer; hypoxia; ischemia; metabolism; microRNA; miR 210; mitochondria

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; MICRORNA; MICRORNA 210; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; BIOCHEMISTRY; CANCER PATIENT; CARDIOVASCULAR DISEASE; CELL CYCLE; CELL SURVIVAL; CEREBROVASCULAR DISEASE; DNA REPAIR; HUMAN; HYPOXIA; ISCHEMIA; MITOCHONDRIAL RESPIRATION; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PROGNOSIS; REVIEW;

ANIMALS; ANOXIA; APOPTOSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; DNA REPAIR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MICE; MICE, INBRED STRAINS; MICRORNAS; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; PROGNOSIS;

EID: 79952137486     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.427     Document Type: Review

References (61)

1. Semenza, G. L., (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625-634.
2. Semenza, G. L., (2010) Vascular responses to hypoxia and ischemia. Arterioscler. Thromb. Vasc. Biol. 30, 648-652.
3. Nakamura, H., Tanimoto, K., Hiyama, K., Yunokawa, M., and, Kawamoto, T., (2008) Human mismatch repair gene, MLH1, is transcriptionally repressed by the hypoxia-inducible transcription factors, DEC1 and DEC2. Oncogene 27, 4200-4209. (Pubitemid 351969910)
4. Bindra, R. S., Schaffer, P. J., Meng, A., Woo, J., and, Maseide, K., (2004) Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol. Cell. Biol. 24, 8504-8518. (Pubitemid 39245072)
5. Hua, Z., Lv, Q., Ye, W., Wong, C. K., and, Cai, G., (2006) MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1, e116.
6. Donker, R. B., Mouillet, J. F., Nelson, D. M., and, Sadovsky, Y., (2007) The expression of Argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts. Mol. Hum. Reprod. 13, 273-279. (Pubitemid 46554745)
7. Guimbellot, J. S., Erickson, S. W., Mehta, T., Wen, H., and, Page, G. P., (2009) Correlation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysis. BMC Med. Genomics 2, 15.
8. Camps, C., Buffa, F. M., Colella, S., Moore, J., and, Sotiriou, C., (2008) hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 14, 1340-1348. (Pubitemid 351413913)
9. Giannakakis, A., Sandaltzopoulos, R., Greshock, J., Liang, S., and, Huang, J., (2008) miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol. Ther. 7, 255-264. (Pubitemid 351590433)
10. Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., and, Romani, S., (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 283, 15878-15883.
11. Pulkkinen, K., Malm, T., Turunen, M., Koistinaho, J., and, Yla-Herttuala, S., (2008) Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett. 582, 2397-2401.
12. Bartel, D. P., (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
13. Leung, A. K., and, Sharp, P. A., (2007) microRNAs: a safeguard against turmoil? Cell 130, 581-585. (Pubitemid 47268068)
14. Kloosterman, W. P., and, Plasterk, R. H., (2006) The diverse functions of microRNAs in animal development and disease. Dev. Cell 11, 441-450. (Pubitemid 44430905)
15. Kulshreshtha, R., Ferracin, M., Negrini, M., Calin, G. A., Davuluri, R. V., and, Ivan, M., (2007) Regulation of microRNA expression: the hypoxic component. Cell Cycle 6, 1426-1431.
16. Crosby, M. E., Kulshreshtha, R., Ivan, M., and, Glazer, P. M., (2009) MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res. 69, 1221-1229.
17. Kulshreshtha, R., Ferracin, M., Wojcik, S. E., Garzon, R., and, Alder, H., (2007) A microRNA signature of hypoxia. Mol. Cell. Biol. 27, 1859-1867.
18. Juan, D., Alexe, G., Antes, T., Liu, H., Madabhushi A., Delisi, C., Ganesan, S., Bhanot, G., and, Liou, L. S., (2010) Identification of a microRNA panel for clear-cell kidney cancer. Urology 75, 835-841.
19. Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., and, Kim, T. Y., (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2, 423-427.
20. Foekens, J. A., Sieuwerts, A. M., Smid, M., Look, M. P., and, de Weerd, V., (2008) Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc. Natl. Acad. Sci. USA 105, 13021-13026.
21. Gee, H. E., Camps, C., Buffa, F. M., Patiar, S., and, Winter, S. C., (2010) hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 116, 2148-2158.
22. Iorio, M. V., Ferracin, M., Liu, C. G., Veronese, A., Spizzo, R., and, Sabbioni, S., (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65, 7065-7070. (Pubitemid 41161233)
23. Porkka, K. P., Pfeiffer, M. J., Waltering, K. K., Vessella, R. L., Tammela, T. L., and, Visakorpi, T., (2007) MicroRNA expression profiling in prostate cancer. Cancer Res. 67, 6130-6135. (Pubitemid 47037493)
24. Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., and, Liggins, A. P., (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141, 672-675. (Pubitemid 351667616)
25. Zhang, H., Gao, P., Fukuda, R., Kumar, G., and, Krishnamachary, B., (2007) HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11, 407-420. (Pubitemid 46670080)
26. Chan, S. Y., Zhang, Y. Y., Hemann, C., Mahoney, C. E., Zweier, J. L., and, Loscalzo, J., (2009) MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 10, 273-284.
27. Fasanaro, P., Greco, S., Lorenzi, M., Pescatori, M., and, Brioschi, M., (2009) An integrated approach for experimental target identification of hypoxia-induced miR-210. J. Biol. Chem. 284, 35134-35143.
28. Favaro, E., Ramachandran, A., McCormick, R., Gee, H., and, Blancher, C., (2010) MicroRNA-210 regulates mitochondrial free radical response to hypoxia and Krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS One 5, e10345.
29. Chen, Z., Li, Y., Zhang, H., Huang, P., and, Luthra, R., (2010) Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 29, 4362-4368.
30. Tong, W. H., and, Rouault, T. A., (2006) Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis. Cell Metab. 3, 199-210.
31. Puissegur, M. P., Mazure, N. M., Bertero, T., Pradelli, L., and, Grosso, S., (2010) miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ., Oct 1. [Epub ahead of print] PMID 20885442.
32. Liu, M., Liu, H., and, Dudley, S. C. Jr., (2010) Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel. Circ. Res. 107, 967-974.
33. Benson, F. E., Baumann, P., and, West, S. C., (1998) Synergistic actions of Rad51 and Rad52 in recombination and DNA repair. Nature 391, 401-404. (Pubitemid 28093516)
34. Sung, P., and, Robberson, D. L., (1995) DNA strand exchange mediated by a RAD51-ssDNA nucleoprotein filament with polarity opposite to that of RecA. Cell 82, 453-461.
35. Bindra, R. S., Gibson, S. L., Meng, A., Westermark, U., and, Jasin, M., (2005) Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res. 65, 11597-11604. (Pubitemid 41821719)
36. Kim, H. W., Haider, H. K., Jiang, S., and, Ashraf, M., (2009) Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J. Biol. Chem. 284, 33161-33168.
37. Tsuchiya, S., Fujiwara, T., Sato, F., Shimada, Y., and, Tanaka, E., (2011) MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J. Biol. Chem. 286, 420-428.
38. Zhang, Z., Sun, H., Dai, H., Walsh, R. M., and, Imakura, M., (2009) MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 8, 2756-2768.
39. van Rooij, E., Sutherland, L. B., Liu, N., Williams, A. H., and, McAnally, J., (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA 103, 18255-18260. (Pubitemid 44871645)
40. Thum, T., Galuppo, P., Wolf, C., Fiedler, J., and, Kneitz, S., (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116, 258-267. (Pubitemid 47196561)
41. Jeyaseelan, K., Lim, K. Y., and, Armugam, A., (2008) MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 39, 959-966. (Pubitemid 351619577)
42. Biswas, S., Roy, S., Banerjee, J., Hussain, S. R., and, Khanna, S., (2010) Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc. Natl. Acad. Sci. USA 107, 6976-6981.
43. Bostjancic, E., Zidar, N., and, Glavac, D., (2009) MicroRNA microarray expression profiling in human myocardial infarction. Dis. Markers 27, 255-268.
44. Li, T., Cao, H., Zhuang, J., Wan, J., and, Guan, M., (2010) Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin. Chim. Acta 412, 66-70.
45. Pineles, B. L., Romero, R., Montenegro, D., Tarca, A. L., and, Han, Y. M., (2007) Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am. J. Obstet. Gynecol. 196, 261.e1-261.e6.
46. Enquobahrie, D. A., Abetew, D. F., Sorensen, T. K., Willoughby, D., Chidambaram, K., and, Williams, M. A., (2010) Placental microRNA expression in pregnancies complicated by preeclampsia. Am. J. Obstet. Gynecol., 204, 178, e-12-21.
47. Zhu, X. M., Han, T., Sargent, I. L., Yin, G. W., and, Yao, Y. Q., (2009) Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am. J. Obstet. Gynecol. 200, 661.e1-661.e7.
48. + current and causes inherited arrhythmias. Circulation 116, 2260-2268. (Pubitemid 350100331)
49. Van Norstrand, D. W., Valdivia, C. R., Tester, D. J., Ueda, K., and, London, B., (2007) Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 116, 2253-2259. (Pubitemid 350100330)
50. Mochel, F., Knight, M. A., Tong, W. H., Hernandez, D., and, Ayyad, K., (2008) Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance. Am. J. Hum. Genet. 82, 652-660.
51. Saito, T., and, Saetrom, P., (2010) MicroRNAs-targeting and target prediction. New Biotechnol. 27, 243-249.
52. Mizuno, Y., Tokuzawa, Y., Ninomiya, Y., Yagi, K., and, Yatsuka-Kanesaki, Y., (2009) miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett. 583, 2263-2268.
53. Qin, L., Chen, Y., Niu, Y., Chen, W., and, Wang, Q., (2010) A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway. BMC Genomics 11, 320.
54. Huang, X., Ding, L., Bennewith, K. L., Tong, R. T., and, Welford, S. M., (2009) Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol. Cell 35, 856-867.
55. Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., and, Lindow, M., (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201.
56. Garzon, R., Marcucci, G., and, Croce, C. M., (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov. 9, 775-789.
57. Ho, A. S., Huang, X., Cao, H., Christman-Skieller, C., and, Bennewith, K., (2010) Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Transl. Oncol. 3, 109-113.
58. Wang, J., Chen, J., Chang, P., LeBlanc, A., and, Li, D., (2009) MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev. Res. 2, 807-813.
59. Hu, S., Huang, M., Li, Z., Jia, F., and, Ghosh, Z., (2010) MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 122, S124-S131.
60. Ivan, M., Harris, A. L., Martelli, F., and, Kulshreshtha, R., (2008) Hypoxia response and microRNAs: no longer two separate worlds. J. Cell Mol. Med. 12, 1426-1431.
61. Covello, K. L., Kehler, J., Yu, H., Gordan, J. D., and, Arsham, A. M., (2006) HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 20, 557-570. (Pubitemid 43345322)